PlainRecalls
FDA Drug Low Class III Terminated

Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only, Manufactured by: Teva Pharmaceuticals USA, 1090 Horsham Rd, North Wales, PA 19454, NDC 63739-0512-10

Reported: March 26, 2014 Initiated: March 3, 2014 #D-1167-2014

Product Description

Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only, Manufactured by: Teva Pharmaceuticals USA, 1090 Horsham Rd, North Wales, PA 19454, NDC 63739-0512-10

Reason for Recall

Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval.

Details

Units Affected
1,557 Boxes
Distribution
Nationwide
Location
Concord, NC

Frequently Asked Questions

What product was recalled?
Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only, Manufactured by: Teva Pharmaceuticals USA, 1090 Horsham Rd, North Wales, PA 19454, NDC 63739-0512-10. Recalled by McKesson Packaging Services. Units affected: 1,557 Boxes.
Why was this product recalled?
Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 26, 2014. Severity: Low. Recall number: D-1167-2014.